National Rare Disease Plan Launch
Thursday, July 17th 2014 16:01
article thumbnailThe National Rare Disease Plan 2014 - 2018, published this month, outlines proposals for a new clinical care programme specifically for the treatment of rare diseases, which affect an estimated 6 to 8 per cent of people in their lifetime....
The Burden of COPD
Monday, July 7th 2014 16:16
article thumbnailEuropean Respiratory Society (ERS) Vice President Professor Jorgen Vestbo together with leading experts examine the current and future burden of chronic obstructive pulmonary disease (COPD) in this excellent video. Alpha-1 antitrypsin deficiency is...
An Easy Guide to Rare Diseases
Saturday, June 21st 2014 14:28
article thumbnailAn Easy Guide to Rare Diseases has been produced to increase awareness about the challenges of living with a rare disease and to highlight the priorities that need to be included in the forthcoming National Plan for Rare Diseases in Ireland. This...
JAMA article: 'The War against Tobacco'
Wednesday, May 21st 2014 07:12
article thumbnail An article published in The Journal of the American Medical Association earlier this year documents the 'war against tobacco' which has been ongoing for the past 50 years in the US and indeed in societies worldwide. It reiterates the stark reality...
What is Alpha-1 Antitrypsin?
Alpha-1 antitrypsin is a vital protein produced by the liver to protect the lungs. It provides protection from the harmful effects of infections and inhaled irritants, particularly tobacco smoke. It can be easily measured by a simple blood test. 
What is Alpha-1 Antitrypsin Deficiency?
Alpha-1 antitrypsin deficiency (Alpha-1) is a genetic condition which, along with cystic fibrosis, is the commonest genetic lung disease in Ireland. It severely affects more than 12,000 people, with another 170,000 carriers also at risk of lung and liver disease. It is a proven genetic risk factor for chronic obstructive pulmonary disease (COPD).
Go to top